“The EU’s executive told member countries they can repurpose hundreds of billions of euros in Covid-19 relief money to fund defense projects, reflecting a radical shift in priorities since the days of the pandemic.”
“the murder rate in 2024 not just falling from the 2020 spike but returning to pre-COVID levels. That brings us to the present, and to a question: Could 2025 see the lowest murder rate ever recorded?”
…
“Fewer people are being killed than they were during a major homicide increase” is not compelling messaging, to be sure. But that’s not what’s happening here. We’re not talking about a record decline after a precipitous surge; we’re talking about a record low, period. While it’s still possible that won’t pan out, the fact that it’s even on the table after a bloody few years is such good news that journalists might even consider leading with it.”
“When it became clear that overdoses had risen dramatically in 2020, experts surmised that it had something to do with the social and economic disruption caused by the COVID-19 pandemic and the government’s response to it—an impression confirmed by subsequent research.
A 2024 study found that “volatile drug use during the COVID-19 pandemic was common, appeared to be driven by structural vulnerability, and was associated with increased overdose risk.” Another study published the same year concluded that “policies limiting in-person activities significantly increased” drug death rates.
If pandemic-related disruption drove the 2020 overdose spike, the return to normal life seems like a plausible explanation for subsequent decreases, although the death toll was still about 14 percent higher last year than it was in 2019. Last fall, University of North Carolina drug researcher Nabarun Dasgupta and his colleagues suggested other possible factors, including wider availability of naloxone, an opioid antagonist that quickly reverses overdoses.”
“A February 2025 review study of ivermectin randomized controlled trials in Annals of Medicine & Surgery concluded that ivermectin showed no significant impact on critical outcomes such as mortality, mechanical ventilation, viral clearance rates, ICU admissions, or hospitalization rates compared to controls. Similarly, a February 2025 review article of randomized controlled trials by a team of Indian pharmaceutical researchers observed that “we consider Ivermectin ineffective in the management of COVID-19 disease, both as treatment and prophylaxis.””
“In addition to tracking deaths attributed to COVID-19, researchers aim to account for those missed by formal diagnoses by calculating excess deaths. Excess deaths are typically defined as the number of deaths during a particular period above the usual, expected number of deaths under normal conditions.”
…
“A February 2024 article in Proceedings of the National Academy of Sciences calculated excess deaths between March 2020 and August 2022, concluding that around 1.2 million Americans had died of COVID-19. A January 2025 analysis in the Journal of the Royal Statistical Society: Statistics in Society Series A calculated excess pandemic mortality in the United States for 2020 and 2021 at 920,731. Interestingly, Stanford biostatistician John Ioannidis, a skeptic of worst-case COVID-19 pandemic claims, and his colleagues calculated in a December 2023 Proceedings of the National Academy of Sciences article that the U.S. suffered 1,220,295 excess deaths between 2020 and 2023. Notably, they also calculated that the U.S. actually experienced 3,456 fewer than expected deaths of Americans aged 14 and under during that period. Considering that all of these calculations use data from 2023 or earlier, they suggest that the Centers for Disease Control and Prevention’s current count of 1,225,281 American deaths from COVID-19 and related causes is somewhat conservative.”
“A June 2024 meta-analysis in the journal Clinical Microbiology Reviews synthesized evidence from more than 100 studies and reviews. It found that masks, “if correctly and consistently worn,” are “effective in reducing transmission of respiratory diseases and show a dose-response effect.” It also found that, N95 and KN95 masks were more effective than surgical or cloth masks. Using data from jurisdictions with mask mandates, the researchers concluded that “mask mandates are, overall, effective in reducing community transmission of respiratory pathogens.” The efficacy of masks alone does not settle the question of mask mandates, which is far more complex.
In their comprehensive 2024 report, Effectiveness of masks and respirators against respiratory infections, researchers associated with the Finnish Institute of Occupational Health reviewed 153 research articles on the effectiveness of mask use against infective agents or airborne droplets and particles. They reported that 128 of the articles they analyzed found masks to be effective. They noted that “systematic reviews of on randomized controlled trial studies in clinical or community settings demonstrated effectiveness in 10 out of 16 studies, and 20 out of 23 studies found mask mandates to be effective.”
“COVID-19 vaccines and boosters have proved to be highly effective in preventing severe cases, hospitalizations, and deaths.”
…
“A September 2024 review in the journal NPJ Vaccines reports that the risk of myocarditis is about six times greater for those who are infected with COVID-19 than for those who are vaccinated. A February 2025 article in the European Heart Journal compared patients who experienced post-vaccine myocarditis to those who experienced post-COVID-19 and conventional myocarditis. The researchers found that post-vaccine myocarditis patients were less likely to be hospitalized and experienced fewer cardiovascular events.”
…
“The most comprehensive analysis of the safety of COVID-19 vaccines is the cohort study of 99 million vaccinated individuals published in April 2024 in Vaccine. The researchers confirmed that the incidences of previously identified rare safety signals following COVID-19 vaccination were quite low.”
…
“By March 2022, Fauci and his colleagues acknowledged “the concept of classical herd immunity may not apply to COVID-19” in The Journal of Infectious Diseases. “Living with COVID-19 is best considered not as reaching a numerical threshold of immunity, but as optimizing population protection without prohibitive restrictions on our daily lives,” they concluded. Population protection, among other things, now involves inoculations updated much like seasonal flu vaccines to boost waning antibodies and to counter emerging variants of the COVID-19 coronavirus. Ultimately, Biden’s 2021 “summer of freedom” turns out to have been a fond but illusory hope of a permanent respite from COVID-19. Given this reality, current COVID-19 vaccines are now primarily designed to prevent severe disease and death rather than infection.”
“A building boom in Austin, Texas has paid off big for renters.
There, residents’ rents have tumbled 22% from their peak in the summer of 2023, Bloomberg reported. The formerly low-cost city took on a new reputation in 2021 as a prohibitively pricey locale, as companies and young workers flocked to the Lone Star State’s capital. Heavy investment in development and ambitious housing policies, however, have flipped the script between renters and landlords.
Nearly all apartments in Austin are doing some sort of special for move-ins, one agent told Bloomberg.”